Bunnage Mark E. sold VRTX

February 24, 2026 · Form 4 insider transaction

Bunnage Mark E. sold 582 shares of Vertex Pharmaceuticals Incorporated at $485.11 per share, a transaction worth $282.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.